IGM Biosciences Inc. (IGMS)
1.70
-0.01 (-0.58%)
At close: Jan 15, 2025, 11:54 AM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| PE Ratio | -1.76 | -3.3 | -6.11 | -33.8 | -8.07 | -0.47 | -0.96 |
| PS Ratio | 204.09 | 661.05 | n/a | n/a | n/a | n/a | n/a |
| PB Ratio | 2.14 | -1.23 | -2.78 | -14.4 | -3.2 | -0.16 | -0.26 |
| P/FCF Ratio | -2.12 | -44 | -7.14 | -32.01 | -7.23 | -0.51 | -0.99 |
| P/OCF Ratio | -2.26 | -120.74 | -7.9 | -40.34 | -7.61 | -0.53 | -1.03 |
| OCF/S Ratio | -90.25 | -5.48 | n/a | n/a | n/a | n/a | n/a |
| Debt / Equity Ratio | 0.20 | -0.07 | -0.08 | -0.06 | -0.14 | -0.08 | n/a |
| Quick Ratio | 8.18 | 9.81 | 8.67 | 21.65 | 27.39 | 0.27 | 0.67 |
| Current Ratio | 8.18 | 9.81 | 8.67 | 21.65 | 26.04 | 0.27 | 0.67 |
| Asset Turnover | 0.01 | 0.00 | n/a | n/a | n/a | n/a | n/a |
| Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Return on Equity (ROE) | -1.21 | 0.37 | 0.45 | 0.43 | 0.40 | 0.35 | 0.27 |
| Return on Assets (ROA) | -0.58 | -0.42 | -0.54 | -0.2 | -0.16 | -5.71 | -7.95 |
| Return on Capital (ROIC) | -0.69 | -0.49 | -0.61 | -0.21 | -0.18 | 4.64 | -26.93 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | -288.59% | -891.77% | n/a | n/a | n/a | n/a | n/a |
| Net Profit Margin | -11.57K% | -20.04K% | n/a | n/a | n/a | n/a | n/a |
| Pretax Profit Margin | -11.54K% | -20.68K% | n/a | n/a | n/a | n/a | n/a |
| Operating Profit Margin | -12.37K% | -21.32K% | n/a | n/a | n/a | n/a | n/a |
| FCF Margin | -9.61K% | -1.50K% | n/a | n/a | n/a | n/a | n/a |
| EBITDA Margin | -11.89K% | -20.76K% | n/a | n/a | n/a | n/a | n/a |